MacroGenics | MGNX - Stock

Aktienkurs
3.60
Täglich Wechseln
0.16 4.65%
Monatlich
7.78%
Jährlich
179.07%
Q2 Prognose
3.50




Stock Veränderung Datum
AbbVie USD 4.95B 13M 2025-12
Amgen USD 6.22B 121M 2025-12
AstraZeneca USD 6.59B 126M 2025-09
Biogen USD 2.17B 41.3M 2025-12
Bristol-Myers Squibb USD 2.76B 21M 2025-09
Daiichi Sankyo JPY 608.55B 93.64B 2025-09
Eli Lilly USD 13.74B 1.56B 2025-12
Genmab DKK 13M 1000K 2025-06
Geron USD 116.64M 21.21M 2025-12
Gilead Sciences USD 1.78B 40M 2025-09
J&J USD 14.19B 45M 2025-12
Karyopharm Therapeutics USD 4.04M 72K 2025-12
MacroGenics USD 7.91M 840K 2025-12
Merck USD 6.44B 157M 2025-09
Pfizer USD 11.47B 201M 2025-09
Puma Biotechnology USD 9.48M 885K 2025-09
Regeneron Pharmaceuticals USD 3.2B 53.6M 2025-12
Roche Holding CHF 7.6B 9M 2025-06